Sharma S, Shrestha A, Koirala M
Department of Anaesthesiology, Tribhuvan University Teaching Hospital, Maharajgunj Medical Campus, Institute of Medicine, Maharajgunj, Kathmandu, Nepal.
Kathmandu Univ Med J (KUMJ). 2019;17(67):178-183.
Background Brachial plexus block is popular choice for upper limb surgeries and offers good and relatively safe anesthesia. Among various approaches supraclavicular approach is the most consistent method for anaesthesia and postoperative pain management in surgery below the elbow joint. Many drugs are used as adjuvants in brachial plexus block for faster onset, denser block and for prolongation of postoperative analgesia. Dexmedetomidine also has been shown to prolong the sensory and motor duration when added as an adjuvant to local anaesthetic in nerve blocks. Objective To assess the effect of adding dexmedetomidine to ropivacaine in brachial block. Method Sixty patients, planned for upper limb surgeries under ultrasound guided brachial block were randomly allocated into two groups. Group RS (n=30) received 30 ml of 0.5% Ropivacaine + 1 ml Normal Saline and Group RD (n=30) received 30 ml of 0.5% Ropivacaine + 0.75 mcg/kg Dexmedetomidine diluted to 1 ml solution. The onset time to sensory and motor blockade were recorded. The duration of sensory and motor block and duration of analgesia were recorded. Result The mean time to onset of sensory block (12.60±2.67 min Vs 22.17±2.81 min) and motor block (14.20±3.22 min Vs 22.53±3.97) in Group RD was significantly faster in Group RD than Group RS. The mean duration of sensory block (838.70±164.11 min Vs 670.20±145.16 min), motor block (804.16±148.71 min Vs 594.93±53.89 min) and duration of analgesia (1193.80±223.11 min Vs 828.23±136.30 min) were significantly longer in Group RD compared to Group RS. The incidence of side effects in both groups were comparable. Conclusion From this study, it can be concluded that addition of Dexmedetomidine 0.75 mcg/ kg to 0.5% Ropivacaine results in early onset of sensory and motor blockade, prolongation of duration of sensory and motor blockade and duration of analgesia postoperatively without any significant side effects.
臂丛神经阻滞是上肢手术常用的麻醉方法,麻醉效果良好且相对安全。在各种臂丛神经阻滞方法中,锁骨上入路是肘关节以下手术麻醉及术后疼痛管理最可靠的方法。许多药物被用作臂丛神经阻滞的辅助用药,以加快起效速度、增强阻滞效果及延长术后镇痛时间。右美托咪定作为局部麻醉药的辅助用药用于神经阻滞时,也已显示可延长感觉和运动阻滞时间。目的:评估在臂丛神经阻滞中右美托咪定与罗哌卡因联合应用的效果。方法:60例计划在超声引导下臂丛神经阻滞下行上肢手术的患者被随机分为两组。RS组(n = 30)接受30 ml 0.5%罗哌卡因+1 ml生理盐水,RD组(n = 30)接受30 ml 0.5%罗哌卡因+0.75 mcg/kg右美托咪定稀释至1 ml溶液。记录感觉和运动阻滞的起效时间、感觉和运动阻滞持续时间以及镇痛持续时间。结果:RD组感觉阻滞(12.60±2.67分钟对22.17±2.81分钟)和运动阻滞(14.20±3.22分钟对22.53±3.97分钟)的平均起效时间明显快于RS组。RD组感觉阻滞平均持续时间(838.70±164.11分钟对670.20±145.16分钟)、运动阻滞平均持续时间(804.16±148.71分钟对594.93±53.89分钟)和镇痛持续时间(1193.80±223.11分钟对828.23±136.30分钟)均明显长于RS组。两组副作用发生率相当。结论:本研究表明,0.5%罗哌卡因中加入0.75 mcg/kg右美托咪定可使感觉和运动阻滞起效更早,延长感觉和运动阻滞持续时间及术后镇痛时间,且无明显副作用。